Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Still not happy about share dilution

Still not happy about share dilution

posted on May 23, 2006 08:07AM
And I won`t be until we turn this process around with a buyback program. But, according to pinksheets.com in 2004, the SB-2 was for 90 million. In 2005, the SB-2 was for 47 million.

I don`t know what it means, but I hope it indicates we are nearing the end of our death spiral financing.

Share
New Message
Please login to post a reply